Skip to main content
APLS logo

APLS · Apellis Pharmaceuticals, Inc.

Track APLS — free
Market Cap
$5.25B
Shares
128.02M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Settlement Date Quantity Price Value
No fails-to-deliver data in the selected range.
Showing 0–0 of 0 settlements
Key facts CIK 1492422 CUSIP 03753U106 13F (30d) 8 filings 5 filers Visit website